Patent · US Active

Compositions comprising PCSK9-binding molecules and methods of use

US11692021B2 · kind B2 · utility

1Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2020
Grant dateJul 4, 2023
Priority date—
Expiry dateJun 15, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/74
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.